Skip to main content

Table 3 Serum angiotensin-converting enzyme 2 (ace2) levels and myocardial infarction (mi) scores in control and acute mi subjects

From: Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence

Subjects

Genotype

N

Serum ACE2 level (ng/mL)

MI severity score

Total

Control

GG

269

6.8±4.5

N/A

GA+AA

91

5.5±3.3

Total

360

6.3±3.9

Acute MI

GG

257

15.9±7.8a

11.6±6.5

GA+AA

94

8.1±5.4b,c

18.8±4.4c

Total

351

13.7±7.2

13.5±4.9

Male

Control

GG

144

6.6±4.7

N/A

GA+AA

63

5.2±3.5

Total

207

6.2±4.2

Acute MI

GG

156

15.7±8.0a

11.7±6.7

GA+AA

69

7.8±5.5b,c

19.0±4.6c

Total

225

13.3±7.5

13.8±5.2

Female

Control

GG

125

7.0±4.4

N/A

GA+AA

28

6.2±3.1

Total

153

6.9±3.5

Acute MI

GG

101

16.2±7.5a

11.4±6.2

GA+AA

25

8.9±5.2b,c

18.2±4.0c

  

Total

126

14.8±8.0

12.8±4.4

  1. Note: Comparisons of means among genotype groups were performed with one-way ANOVA followed by post hoc pairwise comparisons using Tukey's tests in total subjects and by gender. ap<0.05 compared with GG in Control subjects; bp<0.05 compared with GA+AA in Control subjects; cp<0.05 compared with GG in Acute MI subjects.